Hemoglobin Measurement as the First‑Line Investigation in Children with Suspected Thalassemia Major
Pathophysiology of the Clinical Triad
- Skull (frontal) bossing results from massive bone‑marrow expansion that attempts to compensate for chronic severe anemia. 1
- Maxillary enlargement (“chipmunk facies”) is produced by the same marrow hyperplasia mechanism. 2
- Hepatosplenomegaly develops secondary to extramedullary hematopoiesis and iron overload associated with chronic severe anemia. 1
- Chronic severe anemia in thalassemia major drives growth failure through multiple pathways: tissue hypoxia, endocrine dysfunction from iron deposition (pituitary, thyroid, gonads), nutritional deficiencies, and the metabolic burden of ineffective erythropoiesis. 2
Diagnostic Priority of Hemoglobin
- A markedly low hemoglobin level (typically < 7 g/dL in untreated thalassemia major) provides immediate diagnostic confirmation and explains all associated clinical findings. 1
- Hemoglobin measurement alone determines the etiology of short stature, whereas pituitary‑hormone testing evaluates a secondary consequence rather than the primary disorder. 3
Guideline Recommendations (American College of Medical Genetics – ACMG)
- When physical examination reveals dysmorphic features and organomegaly, the evaluation must first identify the underlying syndrome before pursuing isolated short‑stature work‑up. 2
- Testing pituitary function before confirming the hematologic disorder is discouraged; the primary focus should be on confirming severe anemia. 4
- Liver‑function tests may reflect iron overload but do not establish the primary diagnosis; they should be ordered after hemoglobin confirms thalassemia. 1
Clinical Approach Algorithm
Critical Pitfall to Avoid
- Do not initiate isolated short‑stature investigations (bone age, IGF‑1, growth‑hormone stimulation) when characteristic dysmorphic features are present; the ACMG guidelines mandate prioritizing identification of the underlying hematologic condition. 5